Literature DB >> 25077532

Comparison of drusen and modifying genes in autosomal dominant radial drusen and age-related macular degeneration.

Elliott H Sohn1, Kai Wang, Stewart Thompson, Megan J Riker, Jeremy M Hoffmann, Edwin M Stone, Robert F Mullins.   

Abstract

BACKGROUND: Autosomal dominant radial drusen (ADRD), also termed Malattia Leventinese and Doyne honeycomb retinal dystrophy, causes early-onset vision loss because of mutation in EFEMP1. Drusen in an exceedingly rare ADRD human donor eye was compared with eyes affected with age-related macular degeneration (AMD). This study also elucidated whether variations in high-risk AMD genotypes modify phenotypic severity of ADRD.
METHODS: Morphologic and histochemical analyses of drusen in one ADRD donor and seven AMD donors. Evaluation of complement factor H (CFH) and ARMS2/HTRA1 alleles in a cohort of 25 subjects with ADRD.
RESULTS: Autosomal dominant radial drusen had unique onion skin-like lamination but otherwise shared many compositional features with hard, nodular drusen and/or diffuse soft drusen with basal deposits. Autosomal dominant radial drusen also possessed collagen type IV, an extracellular matrix protein that is absent in age-related drusen. Antibodies directed against the membrane attack complex showed robust labeling of ADRD. Vitronectin and amyloid P were present in drusen of both types. High-risk alleles in the CFH and ARMS2/HTRA1 genes were not associated with increasing ADRD severity.
CONCLUSION: Drusen from ADRD and AMD exhibit overlap of some major constituents, but ADRD exhibit distinct alterations in the extracellular matrix that are absent in AMD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25077532      PMCID: PMC5513174          DOI: 10.1097/IAE.0000000000000263

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  37 in total

1.  Mutations in ABCC6 cause pseudoxanthoma elasticum.

Authors:  A A Bergen; A S Plomp; E J Schuurman; S Terry; M Breuning; H Dauwerse; J Swart; M Kool; S van Soest; F Baas; J B ten Brink; P T de Jong
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  Responsiveness of choroidal neovascular membranes in patients with R345W mutation in fibulin 3 (Doyne honeycomb retinal dystrophy) to anti-vascular endothelial growth factor therapy.

Authors:  Elliott H Sohn; Praveen J Patel; Robert E MacLaren; Feisal A Adatia; Bishwanath Pal; Andrew R Webster; Adnan Tufail
Journal:  Arch Ophthalmol       Date:  2011-12

3.  Improved method for obtaining 3-microns cryosections for immunocytochemistry.

Authors:  L K Barthel; P A Raymond
Journal:  J Histochem Cytochem       Date:  1990-09       Impact factor: 2.479

4.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

5.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

6.  Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells.

Authors:  G S Hageman; R F Mullins; S R Russell; L V Johnson; D H Anderson
Journal:  FASEB J       Date:  1999-03       Impact factor: 5.191

7.  Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial.

Authors: 
Journal:  Ophthalmology       Date:  2006-11       Impact factor: 12.079

Review 8.  A role for local inflammation in the formation of drusen in the aging eye.

Authors:  Don H Anderson; Robert F Mullins; Gregory S Hageman; Lincoln V Johnson
Journal:  Am J Ophthalmol       Date:  2002-09       Impact factor: 5.258

9.  ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations.

Authors:  Elod Kortvely; Stefanie M Hauck; Gabriele Duetsch; Christian J Gloeckner; Elisabeth Kremmer; Claudia S Alge-Priglinger; Cornelia A Deeg; Marius Ueffing
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-20       Impact factor: 4.799

Review 10.  Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.

Authors:  Maurizio B Parodi; Gianni Virgili; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08
View more
  13 in total

1.  Clinically detectable drusen domains in fibulin-5-associated age-related macular degeneration (AMD) : Drusen subdomains in fibulin-5 AMD.

Authors:  Murat Kucukevcilioglu; Chetankumar B Patel; Edwin M Stone; Stephen R Russell
Journal:  Int Ophthalmol       Date:  2015-12-23       Impact factor: 2.031

Review 2.  Mapping wild-type and R345W fibulin-3 intracellular interactomes.

Authors:  John D Hulleman; Joseph C Genereux; Annie Nguyen
Journal:  Exp Eye Res       Date:  2016-10-21       Impact factor: 3.467

3.  The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning.

Authors:  Robert F Mullins; Desi P Schoo; Elliott H Sohn; Miles J Flamme-Wiese; Grefachew Workamelahu; Rebecca M Johnston; Kai Wang; Budd A Tucker; Edwin M Stone
Journal:  Am J Pathol       Date:  2014-09-07       Impact factor: 4.307

4.  HYPERSPECTRAL AUTOFLUORESCENCE IMAGING OF DRUSEN AND RETINAL PIGMENT EPITHELIUM IN DONOR EYES WITH AGE-RELATED MACULAR DEGENERATION.

Authors:  Yuehong Tong; Tal Ben Ami; Sungmin Hong; Rainer Heintzmann; Guido Gerig; Zsolt Ablonczy; Christine A Curcio; Thomas Ach; R Theodore Smith
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

5.  A local complement response by RPE causes early-stage macular degeneration.

Authors:  Rosario Fernandez-Godino; Donita L Garland; Eric A Pierce
Journal:  Hum Mol Genet       Date:  2015-07-21       Impact factor: 6.150

6.  Differential tolerance of 'pseudo-pathogenic' tryptophan residues in calcium-binding EGF domains of short fibulin proteins.

Authors:  Annie Nguyen; John D Hulleman
Journal:  Exp Eye Res       Date:  2014-12-03       Impact factor: 3.467

7.  Mutations in CTNNA1 cause butterfly-shaped pigment dystrophy and perturbed retinal pigment epithelium integrity.

Authors:  Nicole T M Saksens; Mark P Krebs; Frederieke E Schoenmaker-Koller; Wanda Hicks; Minzhong Yu; Lanying Shi; Lucy Rowe; Gayle B Collin; Jeremy R Charette; Stef J Letteboer; Kornelia Neveling; Tamara W van Moorsel; Sleiman Abu-Ltaif; Elfride De Baere; Sophie Walraedt; Sandro Banfi; Francesca Simonelli; Frans P M Cremers; Camiel J F Boon; Ronald Roepman; Bart P Leroy; Neal S Peachey; Carel B Hoyng; Patsy M Nishina; Anneke I den Hollander
Journal:  Nat Genet       Date:  2015-12-21       Impact factor: 38.330

8.  Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy.

Authors:  Irene Tom; Victoria C Pham; Kenneth J Katschke; Wei Li; Wei-Ching Liang; Johnny Gutierrez; Andrew Ah Young; Isabel Figueroa; Shadi Toghi Eshghi; ChingWei V Lee; Jitendra Kanodia; Scott J Snipas; Guy S Salvesen; Phillip Lai; Lee Honigberg; Menno van Lookeren Campagne; Daniel Kirchhofer; Amos Baruch; Jennie R Lill
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-28       Impact factor: 11.205

9.  Fibulin-3 knockout mice demonstrate corneal dysfunction but maintain normal retinal integrity.

Authors:  Steffi Daniel; Marian Renwick; Viet Q Chau; Shyamtanu Datta; Prabhavathi Maddineni; Gulab Zode; Emma M Wade; Stephen P Robertson; W Matthew Petroll; John D Hulleman
Journal:  J Mol Med (Berl)       Date:  2020-09-22       Impact factor: 4.599

10.  First reported case of Doyne honeycomb retinal dystrophy (Malattia Leventinese/autosomal dominant drusen) in Scandinavia.

Authors:  Inger Norlyk Sheyanth; Ihab Bishara Lolas; Henrik Okkels; Ligor Pradeep Kiruparajan; Søren Kromann Abildgaard; Michael Bjørn Petersen
Journal:  Mol Genet Genomic Med       Date:  2021-03-10       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.